The safety of sublingual immunotherapy with one or more allergens in adults.
Lombardi
C
C
Allergy & Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy.
Gargioni
S
S
Cottini
M
M
Canonica
G W
GW
Passalacqua
G
G
D000286:Administration, Sublingual; D000293:Adolescent; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000485:Allergens / Q000276:immunology*; D015331:Cohort Studies; D003888:Desensitization, Immunologic / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods; D007558:Italy; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D012720:Severity of Illness Index; D012882:Skin Tests
D000485:Allergens; D007166:Immunosuppressive Agents